BioSpace News Archive

Alcobra Prices Public Offering Of Ordinary Shares

January 9, 2015
·
4 min read
Drug Development

Portola Pharmaceuticals, Inc. Announces Phase 3 ANNEXA-R Study Of Andexanet Alfa And Factor Xa Inhibitor XARELTO® (Rivaroxaban) Met Primary Endpoint With High Statistical Significance

January 9, 2015
·
10 min read
Drug Development

SAGE Therapeutics Reports Updated Data From Ongoing Clinical Trial And Emergency Use Program Of SAGE-547 In Patients With Super-Refractory Status Epilepticus

January 9, 2015
·
10 min read
Ally Bridge Group Expands Global Biopharmaceutical Investments

January 9, 2015
·
3 min read
Pharm Country

Arrowhead Issues Diligence And Valuation Report On Hemispherx Biopharma

January 9, 2015
·
5 min read
Biotech Bay

Relypsa, Inc. Announces New Employment Inducement Grants

January 9, 2015
·
1 min read
Business

Marken (Formerly known as Marken Time Critical) Announces New General Manager For Argentina And Brazil

January 9, 2015
·
1 min read
Biotech Beach

Celladon Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

January 9, 2015
·
4 min read
Business

Egalet Appoints Deanne F. Melloy As Chief Commercial Officer

January 9, 2015
·
4 min read
Genetown

Gelesis Announces Initiation Of A Six-Month Weight Loss Study With Gelesis100

January 9, 2015
·
3 min read